Maintaining and Strengthening Relationships through Strategic Shareholdings and Verifying the Rationale for Holding Them
First written in FY2019. 5 of 7 entries say "Restated". Latest entry: FY2026.
- FY2026AdvancedAnnual report
「During the fiscal year, the number of holdings that decreased was 1 issue, with total sale proceeds of ¥67 million. The Company annually scrutinises whether the purpose of holding each share is appropriate and whether the benefits and risks associated with holding it are commensurate with the cost of capital, among other matters, and verifies the appropriateness of the holding at meetings of the Board of Directors.」
The Company sold 1 issue of cross-shareholdings based on its verification of the rationale for holding it. - FY2024RestatedAnnual report
「The Company annually scrutinises whether the purpose of holding each share is appropriate and whether the benefits and risks associated with holding it are commensurate with the cost of capital, among other matters, and verifies the appropriateness of the holding at meetings of the Board of Directors.」
The Company has continued its policy of annually verifying whether the benefits and risks of cross-shareholdings are commensurate with the cost of capital. - FY2023RestatedAnnual report
「The Company annually scrutinises whether the purpose of holding each share is appropriate and whether the benefits and risks associated with holding it are commensurate with the cost of capital, among other matters, and verifies the appropriateness of the holding at meetings of the Board of Directors.」
The Company has continued its policy of annually verifying whether the benefits and risks of cross-shareholdings are commensurate with the cost of capital. - FY2022RestatedAnnual report
「The Company annually scrutinises whether the purpose of holding each share is appropriate and whether the benefits and risks associated with holding it are commensurate with the cost of capital, among other matters, and verifies the appropriateness of the holding at meetings of the Board of Directors.」
The Company has continued its policy of annually verifying whether the benefits and risks of cross-shareholdings are commensurate with the cost of capital. - FY2021RestatedAnnual report
「The Company annually scrutinises whether the purpose of holding each share is appropriate and whether the benefits and risks associated with holding it are commensurate with the cost of capital, among other matters, and verifies the appropriateness of the holding at meetings of the Board of Directors.」
The Company has continued its policy of annually verifying whether the benefits and risks of cross-shareholdings are commensurate with the cost of capital. - FY2020RestatedAnnual report
「The Company annually scrutinises whether the purpose of holding each share is appropriate and whether the benefits and risks associated with holding it are commensurate with the cost of capital, among other matters, and verifies the appropriateness of the holding at meetings of the Board of Directors.」
The Company has continued its policy of annually verifying whether the benefits and risks of cross-shareholdings held to maintain and strengthen relationships with customers are commensurate with the cost of capital. - FY2019First statedAnnual report
「The Company annually scrutinises whether the purpose of holding each share is appropriate and whether the benefits and risks associated with holding it are commensurate with the cost of capital, among other matters, and verifies the appropriateness of the holding at meetings of the Board of Directors.」
The Company has stated a policy of annually scrutinising whether the benefits and risks of cross-shareholdings held to maintain and strengthen relationships with customers are commensurate with the cost of capital, and verifying the appropriateness of the holdings at meetings of the Board of Directors.